CDKN2B Antikörper
Kurzübersicht für CDKN2B Antikörper (ABIN1497444)
Target
Alle CDKN2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human CDKN2B / p15 INK4b
-
Aufreinigung
- Protein A/G purified
-
Immunogen
-
Full length human recombinant protein of human CDKN2B(NP_004927) produced in HEK293T cell.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Approved: Flo (1:100), IHC, IHC-P (1:150), WB (1:2000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Andere Bezeichnung
- CDKN2B / p15 INK4b
-
Hintergrund
-
Name/Gene ID: CDKN2B
Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15 -
Gen-ID
- 1030
-
NCBI Accession
- NP_004927
-
UniProt
- P42772
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-